GeneEx, Inc. is a medical device company developing noninvasive, rapid, point of care techniques for diagnosis and prediction of disease numerous autoimmune and infectious diseases, including periodontitis, type-1 diabetes, and systemic fungal infections.
GeneEx's team of inventors developed much of the company's technology at the UF College of Dentistry. Jeffrey Hillman, DMD, Ph.D has founded two other successful biomedical start-ups, iviGene Corporation and Oragenics. Another inventor and iviGene co-founder, Ann Progulske-Fox, Ph.D is Director of the University's Center for Molecular Microbiology. Inventor Martin Handfield, M.Sc., Ph.D, is a co-founder of iviGene and a Director of EpiCure Solutions Corporation. Dr. Michael Clare- Salzler, MD is an Associate Professor with the UF College of Medicine Department of Pathology.
CEO and Director Jack Wilkens has over 35 years of executive management experience with companies including Inverness Medical Innovations, Inc. and it subsidiary Unipath, Johnson & Johnson's diabetes operations in Inverness, Scotland, Medical Imaging Systems with Sterling Diagnostics/AGFA, and Polaroid Corporation.
UF's Office of Technology Licensing helped introduce GeneEx to a number of investors and to date they have successfully raised over two million dollars from angel and private investors and a venture capital firm.